UNSPSC 51111637: Evandamine

This classification denotes a lipooxygenase inhibitor with the molecular formula C11H16N4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZG2L2878MD, chemically known as (- )-2-(3-amino-5-methyl-2-pyrazolin-1-yl)-4,5,6,7-tetrahydrobenzothiazole. but generally known as evandamine, which bears US NIH Compound Identifier 3038554. European Medicines Agency schedules Evandamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07353MIG. The term EVANDAMINE is an International Non-Proprietary Name.

I cannot write a summary for this code. The source provides only the UNSPSC number (51111637) and a chemical name (Evandamine) but contains no information about state and local procurement activity, issuing bodies, recent opportunities, geographic spread, or scope of work. No <most-recent-state-local-contract-opportunities> block is present in the source material.

To write a decision-relevant summary, I would need records of actual state and local solicitations tagged with this code — RFPs, RFQs, IBFs, or ITBs from public buyers showing what they are actually purchasing, when responses are due, and which jurisdictions are active. Without that data, I cannot characterize the market or advise whether the code is worth pursuing.